chr3-151338010-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_022788.5(P2RY12):c.836T>C(p.Val279Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000465 in 1,614,154 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V279M) has been classified as Uncertain significance.
Frequency
Consequence
NM_022788.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
P2RY12 | NM_022788.5 | c.836T>C | p.Val279Ala | missense_variant | 3/3 | ENST00000302632.4 | |
MED12L | NM_001393769.1 | c.2251-12049A>G | intron_variant | ENST00000687756.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
P2RY12 | ENST00000302632.4 | c.836T>C | p.Val279Ala | missense_variant | 3/3 | 1 | NM_022788.5 | P1 | |
MED12L | ENST00000687756.1 | c.2251-12049A>G | intron_variant | NM_001393769.1 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152194Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000518 AC: 13AN: 251046Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135672
GnomAD4 exome AF: 0.0000239 AC: 35AN: 1461842Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 727216
GnomAD4 genome AF: 0.000263 AC: 40AN: 152312Hom.: 1 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 05, 2023 | The c.836T>C (p.V279A) alteration is located in exon 3 (coding exon 1) of the P2RY12 gene. This alteration results from a T to C substitution at nucleotide position 836, causing the valine (V) at amino acid position 279 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 09, 2023 | This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 279 of the P2RY12 protein (p.Val279Ala). This variant is present in population databases (rs761528306, gnomAD 0.09%). This variant has not been reported in the literature in individuals affected with P2RY12-related conditions. ClinVar contains an entry for this variant (Variation ID: 2138834). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at